September 2, 2010
Oncolytics Biotech® Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by the Gynecologic Oncology Group and Sponsored by the National Cancer Institute
|
August 5, 2010
Oncolytics Biotech® Inc. to Present at 30th Annual Canaccord Genuity Growth Conference
|
July 29, 2010
Oncolytics Biotech(R)Inc. Announces Second Quarter 2010 Results
|
July 19, 2010
Oncolytics Biotech® Inc. Receives No Objection Letter from Health Canada to Conduct Phase 3 Trial of REOLYSIN® in Head and Neck Cancers
|
June 17, 2010
Oncolytics Biotech® Inc. Announces Issuance of 35th U.S. Patent
|
June 7, 2010
Oncolytics Biotech(R) Inc. Collaborators Present Positive Updated U.K. Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the ASCO Annual Meeting.
|
June 4, 2010
Oncolytics Biotech® Inc. To Host Conference Call to Discuss Updated U.K. Phase I/II Trial Head and Neck Cancer Data Being Presented at the ASCO Annual Meeting
|
June 3, 2010
Oncolytics Biotech® Inc. to Present at the 9th Annual Needham Healthcare Conference
|
June 1, 2010
Oncolytics Biotech® Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN® in Head and Neck Cancers
|
May 26, 2010
Oncolytics Biotech® Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial
|
| Page 1 Of 3 |
| Next |
